世界银行-国际金融公司在制药和生命科学领域的投资：集群项目绩效评估报告的结果（英）

Findings from Clustered Project Performance Assessment Reports The International Finance Corporation’s Investments in the Pharmaceutical and Life Sciences SectorJune 2025Public Disclosure AuthorizedPublic Disclosure AuthorizedPublic Disclosure AuthorizedPublic Disclosure Authorized© 2025 International Bank for Reconstruction and Development / The World Bank1818 H Street NW Washington, DC 20433Telephone: 202-473-1000Internet: www.worldbank.orgCOVER PHOTOShutterstock/IM ImageryEDITING AND PRODUCTIONAmanda O’BrienGRAPHIC DESIGNRafaela Sarinho This work is a product of the staff of The World Bank with external contributions. The findings, interpretations, and conclusions ex-pressed in this work do not necessarily reflect the views of The World Bank, its Board of Executive Directors, or the governments they represent.The World Bank does not guarantee the accuracy of the data included in this work. The boundaries, colors, denominations, and other information shown on any map in this work do not imply any judgment on the part of The World Bank concerning the legal status of any territory or the endorsement or acceptance of such boundaries.RIGHTS AND PERMISSIONSThe material in this work is subject to copyright. Because The World Bank encourages dissemination of its knowledge, this work may be reproduced, in whole or in part, for noncommercial purposes as long as full attribution to this work is given.Any queries on rights and licenses, including subsidiary rights, should be addressed to World Bank Publications, The World Bank Group, 1818 H Street NW, Washington, DC 20433, USA; fax: 202-522-2625; e-mail: pubrights@worldbank.org.ContentsAbbreviations 5Acknowledgments 6Overview 71. Pharmaceutical Industry—Background ---------------------------------------------------------------------------------------------------112. Pharmaceutical Market Trends -----------------------------------------------------------------------------------------------------------------143. The World Bank and International Finance Corporation Strategy in Pharma and Life Sciences ---------174. The International Finance Corporation’s Portfolio in Pharma and Life Sciences ----------------------------------215. Findings -----------------------------------------------------------------------------------------------------------------------------------------------------256. Looking Forward ---------------------------------------------------------------------------------------------------------------------------------------36Glossary 38Bibliography 41BoxesBox 4.1. Pharma Manufacturing Projects (five projects) 23Box 4.2. Pharma Distribution Projects (two projects) 23FiguresFigure 1.1. Main Product Segments of the Pharmaceutical Industry 11Figure 1.2. Sustainable Development Goal 3 12Figure 1.3. High-Dose Courses of Methotrexate (an Oncology Drug) Needed Annually, by Country Income Group 13Figure 2.1. Growth of Global Generics Market, 2017–22 14Figure 2.2. Share of Gen